Respirerx Pharmaceuticals Inc.
Records under this name other than the patents Respirerx Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Respirerx Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,642,633 | Di-substituted amides for enhancing glutamatergic synaptic responses Lapsed on the fee record Ended Feb 4, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2026 | USPTO record |
| US 8,507,482 | Bicyclic amide derivatives for enhancing glutamatergic synaptic responses Lapsed on the fee record Ended Aug 13, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | USPTO record |
| US 8,404,682 | Di-substituted amides for enhancing glutamatergic synaptic responses Lapsed on the fee record Ended Mar 26, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 26, 2025 | USPTO record |
| US 9,492,440 | Bicyclic amides for enhancing glutamatergic synaptic responses Lapsed on the fee record Ended Nov 15, 2024 · USPTO record | Lapsed on the fee record | Ended Nov 15, 2024 | USPTO record |
| US 8,263,591 | Bicyclic amides for enhancing glutamatergic synaptic responses Lapsed on the fee record Ended Sep 11, 2024 · USPTO record | Lapsed on the fee record | Ended Sep 11, 2024 | USPTO record |
| US 8,168,632 | Bicyclic Amide Derivatives for the Treatmet of Respiratory Disorders Lapsed on the fee record Ended May 1, 2024 · Low confidence | Lapsed on the fee record | Ended May 1, 2024 | Low confidence |
| US 8,013,003 | Di-Substituted Amides for Enhancing Glutamatergic Synaptic Responses Lapsed on the fee record Ended Sep 6, 2023 · High confidence | Lapsed on the fee record | Ended Sep 6, 2023 | High confidence |
| US 8,110,584 | Methods for the Treatment of Respiratory Depression Lapsed on the fee record Ended Feb 7, 2020 · Medium confidence | Lapsed on the fee record | Ended Feb 7, 2020 | Medium confidence |